Smith & Nephew (SNN) Change in Accured Expenses (2009 - 2018)
Smith & Nephew (SNN) posted quarterly Change in Accured Expenses of $51.0 million for Q4 2018, little changed year-on-year from $51.0 million in Q4 2017, and little changed on a QoQ basis from $51.0 million in Q4 2017.
Smith & Nephew (SNN) Change in Accured Expenses (2009 - 2018) Analysis & Trends
Smith & Nephew (SNN) has reported Change in Accured Expenses for 8 consecutive years, with $51.0 million the latest figure, recorded in Q4 2018.
- Quarterly Change in Accured Expenses changed 0.0% year-over-year to $51.0 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $186.0 million (up 18.47% YoY) and the FY2011 annual result came in at $8.0 million, down 46.67% from the prior year.
- Change in Accured Expenses steadied at $51.0 million in Q4 2018 per SNN's latest filing, from $51.0 million in the prior quarter.
- Over the last five years, Change in Accured Expenses for SNN reached as high as $51.0 million in Q4 2017 and fell as low as $22.0 million in Q4 2014.
- A 5-year average of $41.6 million and a median of $46.0 million in 2016 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2015 — Change in Accured Expenses jumped 72.73% — and 2018, when it changed 0.0%.
- Year by year, Change in Accured Expenses stood at $22.0 million in 2014, then soared by 72.73% to $38.0 million in 2015, then gained by 21.05% to $46.0 million in 2016, then grew by 10.87% to $51.0 million in 2017, then changed by 0.0% to $51.0 million in 2018.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $51.0 million, $51.0 million, and $46.0 million for Q4 2018, Q4 2017, and Q4 2016 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 74.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 51.00 Mn |
| Dec 31, 2018 | 51.00 Mn |
| Dec 31, 2017 | 51.00 Mn |
| Dec 31, 2017 | 51.00 Mn |
| Dec 31, 2016 | 46.00 Mn |
| Dec 31, 2016 | 46.00 Mn |
| Dec 31, 2015 | 38.00 Mn |
| Dec 31, 2015 | 38.00 Mn |
| Dec 31, 2014 | 22.00 Mn |
| Dec 31, 2014 | 22.00 Mn |
| Dec 31, 2011 | 2.00 Mn |
| Dec 31, 2011 | 2.00 Mn |
| Sep 30, 2011 | 2.00 Mn |
| Sep 30, 2011 | 2.00 Mn |
| Jun 30, 2011 | 2.00 Mn |
| Jun 30, 2011 | 2.00 Mn |
| Mar 31, 2011 | 2.00 Mn |
| Mar 31, 2011 | 2.00 Mn |
| Dec 31, 2010 | 4.00 Mn |
| Dec 31, 2010 | 4.00 Mn |